A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough

Trial Profile

A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Orvepitant (Primary)
  • Indications Cough
  • Focus Therapeutic Use
  • Acronyms volcano-2
  • Sponsors NeRRe Therapeutics
  • Most Recent Events

    • 01 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 27 Mar 2017 Planned initiation date changed from 1 Apr 2017 to 8 May 2017.
    • 19 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top